In contrast to 5-LO and COX2, a downstream leukotriene metabolizing enzyme LTA4H had significant associations with the decline in DLCO, a parameter that depends not solely on lung structure and volume, but which is also influenced by lung perfusion and pulmonary hypertension [33]. The gene discussed is PTGS2; the disease is pulmonary hypertension.